{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:25:59Z","timestamp":1786980359180,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00595-020-01989-6","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T11:02:46Z","timestamp":1584010966000},"page":"1049-1055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration to assess tumor-programmed cell death ligand-1 expression in mediastinal lymph nodes metastasized from non-small cell lung cancer"],"prefix":"10.1007","volume":"50","author":[{"given":"Katsutaka","family":"Mineura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Hamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Kayawake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satona","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yojiro","family":"Yutaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi","family":"Menju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyofumi F.","family":"Chen-Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"issue":"10027","key":"1989_CR1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim DW, Felip E, P\u00e9rez-Gracia JL, Han JY, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387(10027):1540\u201350.","journal-title":"Lancet"},{"issue":"19","key":"1989_CR2","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, Hui R, Cs\u0151szi T, F\u00fcl\u00f6p A, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016;375(19):1823\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"1989_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, Crin\u00f2 L, Eberhardt WE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373(2):123\u201335.","journal-title":"N Engl J Med"},{"issue":"17","key":"1989_CR4","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373(17):1627\u201339.","journal-title":"N Engl J Med"},{"issue":"10066","key":"1989_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","volume":"389","author":"A Rittmeyer","year":"2017","unstructured":"Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet. 2017;389(10066):255\u201365.","journal-title":"Lancet"},{"issue":"22","key":"1989_CR6","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018;378(22):2078\u201392.","journal-title":"N Engl J Med"},{"issue":"21","key":"1989_CR7","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","volume":"379","author":"L Paz-Ares","year":"2018","unstructured":"Paz-Ares L, Luft A, Vicente D, Tafreshi A, G\u00fcm\u00fc\u015f M, Mazi\u00e8res J, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379(21):2040\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"1989_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jjco\/hyt013","volume":"44","author":"T Higashi","year":"2014","unstructured":"Higashi T, Nakamura F, Shibata A, Emgori Y, Nishimoto H. The national database of hospital-based cancer registries: a nationwide infrastructure to support evidence-based cancer care and cancer control policy in Japan. Jpn J Clin Oncol. 2014;44(1):2\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1989_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ypmed.2016.04.015","volume":"89","author":"M Usman Ali","year":"2016","unstructured":"Usman Ali M, Miller J, Peirson L, Fitzpatrick-Lewis D, Kenny M, Sherifali D, et al. Screening for lung cancer: a systematic review and meta-analysis. Prev Med. 2016;89:301\u201314.","journal-title":"Prev Med"},{"issue":"2","key":"1989_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/JTO.0000000000000388","volume":"10","author":"SW Um","year":"2015","unstructured":"Um SW, Kim HK, Jung SH, Han J, Lee KJ, Park HY, et al. Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol. 2015;10(2):331\u20137.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"1989_CR11","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jtcvs.2016.12.048","volume":"153","author":"K Czarnecka-Kujawa","year":"2017","unstructured":"Czarnecka-Kujawa K, Rochau U, Siebert U, Atenafu E, Darling G, Waddell TK, et al. Cost-effectiveness of mediastinal lymph node staging in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017;153(6):1567\u201378.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"1989_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/PAI.0000000000000408","volume":"24","author":"C Roach","year":"2016","unstructured":"Roach C, Zhang N, Corigliano E, Jansson M, Toland G, Ponto G, et al. Development of a companion diagnostic PD-L1 immunohistochemistry assay for pembrolizumab therapy in non-small-cell lung cancer. Appl Immunohistochem Mol Morphol. 2016;24(6):392\u20137.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"1989_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.chest.2018.07.017","volume":"154","author":"KK Sakata","year":"2018","unstructured":"Sakata KK, Midthun DE, Mullon JJ, Kern RM, Nelson DR, Edell ES, et al. Comparison of programmed death ligand-1 immunohistochemical staining between endobronchial ultrasound transbronchial needle aspiration and resected lung cancer specimens. Chest. 2018;154(4):827\u201337.","journal-title":"Chest"},{"issue":"5","key":"1989_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.cllc.2016.12.002","volume":"18","author":"R Sakakibara","year":"2017","unstructured":"Sakakibara R, Inamura K, Tambo Y, Ninomiya H, Kitazono S, Yanagitani N, et al. EBUS-TBNA as a promising method for the evaluation of tumor PD-L1 expression in lung cancer. Clin Lung Cancer. 2017;18(5):527\u201334.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"1989_CR15","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1186\/s12885-019-5773-3","volume":"19","author":"A Tsunoda","year":"2019","unstructured":"Tsunoda A, Morikawa K, Inoue T, Miyazawa T, Hoshikawa M, Takagi M, et al. A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer. BMC Cancer. 2019;19(1):546.","journal-title":"BMC Cancer"},{"issue":"12","key":"1989_CR16","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/cncy.21937","volume":"125","author":"JJ Heymann","year":"2017","unstructured":"Heymann JJ, Bulman WA, Swinarski D, Pagan CA, Crapanzano JP, Haghighi M, et al. PD-L1 expression in non-small cell lung carcinoma: comparison among cytology, small biopsy, and surgical resection specimens. Cancer Cytopathol. 2017;125(12):896\u2013907.","journal-title":"Cancer Cytopathol"},{"key":"1989_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2019.07.033","volume":"136","author":"G Wang","year":"2019","unstructured":"Wang G, Ionescu DN, Lee CH, Hiruki T, Myers R, Shaipanich T, et al. PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer. Lung Cancer. 2019;136:1\u20135.","journal-title":"Lung Cancer"},{"issue":"10","key":"1989_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1513\/AnnalsATS.201801-045OC","volume":"15","author":"G Labarca","year":"2018","unstructured":"Labarca G, Folch E, Jantz M, Mehta HJ, Majid A, Fernandez-Bussy S. Adequacy of samples obtained by endobronchial ultrasound with transbronchial needle aspiration for molecular analysis in patients with non-small cell lung cancer: systematic review and meta-analysis. Ann Am Thorac Soc. 2018;15(10):1205\u201316.","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"1989_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1159\/000368857","volume":"88","author":"EH van der Heijden","year":"2014","unstructured":"van der Heijden EH, Casal RF, Trisolini R, Steinfort DP, Hwangbo B, Nakajima T, et al. Guideline for the acquisition and preparation of conventional and endobronchial ultrasound-guided transbronchial needle aspiration specimens for the diagnosis and molecular testing of patients with known or suspected lung cancer. Respiration. 2014;88(6):500\u201317.","journal-title":"Respiration"},{"issue":"2","key":"1989_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/crj.12985","volume":"13","author":"T Cicek","year":"2019","unstructured":"Cicek T, Ozturk A, Y\u0131lmaz A, Aktas Z, Demirag F, Akyurek N. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer. Clin Respir J. 2019;13(2):92\u20137.","journal-title":"Clin Respir J"},{"issue":"2","key":"1989_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"3","key":"1989_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transpl. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"1989_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/JTO.0000000000000085","volume":"9","author":"E Matthew","year":"2014","unstructured":"Matthew E, Philip AJC, Julie M, Paul B, Helen D, Leena J, et al. EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes. J Thorac Oncol. 2014;9(3):370\u20136.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"1989_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1378\/chest.15-1216","volume":"149","author":"MM Wahidi","year":"2016","unstructured":"Wahidi MM, Herth F, Yasufuku K, Shepherd RW, Yarmus L, Chawla M, et al. Technical aspects of endobronchial ultrasound-guided transbronchial needle aspiration: CHEST guideline and expert panel report. Chest. 2016;149(3):816\u201335.","journal-title":"Chest"},{"issue":"1","key":"1989_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1378\/chest.98.1.59","volume":"98","author":"RD Davenport","year":"1990","unstructured":"Davenport RD. Rapid on-site evaluation of transbronchial aspirates. Chest. 1990;98(1):59\u201361.","journal-title":"Chest"},{"issue":"4","key":"1989_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.chest.2017.11.004","volume":"153","author":"IS Sehgal","year":"2018","unstructured":"Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Impact of rapid on-site cytological evaluation (ROSE) on the diagnostic yield of transbronchial needle aspiration during mediastinal lymph node sampling: systematic review and meta-analysis. Chest. 2018;153(4):929\u201338.","journal-title":"Chest"},{"issue":"1","key":"1989_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000346998","volume":"86","author":"M Mondoni","year":"2013","unstructured":"Mondoni M, Carlucci P, Di Marco F, Rossi S, Santus P, D'Adda A, et al. Rapid on-site evaluation improves needle aspiration sensitivity in the diagnosis of central lung cancers: a randomized trial. Respiration. 2013;86(1):52\u20138.","journal-title":"Respiration"},{"issue":"2","key":"1989_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000084050","volume":"72","author":"AH Diacon","year":"2005","unstructured":"Diacon AH, Schuurmans MM, Theron J, Louw M, Wright CA, Brundyn K, et al. Utility of rapid on-site evaluation of transbronchial needle aspirates. Respiration. 2005;72(2):182\u20138.","journal-title":"Respiration"},{"issue":"6","key":"1989_CR29","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1378\/chest.15-0583","volume":"148","author":"R Trisolini","year":"2015","unstructured":"Trisolini R, Cancellieri A, Tinelli C, de Biase D, Valentini I, Casadei G, et al. Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping. Chest. 2015;148(6):1430\u20137.","journal-title":"Chest"},{"issue":"5","key":"1989_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cllc.2015.03.008","volume":"16","author":"S Kitazono","year":"2015","unstructured":"Kitazono S, Fujikawa Y, Tsuta K, Utsumi H, Kanda S, Horinouchi H, et al. Reliability of small biopsy samples compared with resected specimens for the determination of programmed death-ligand 1 expression in non-small-cell lung cancer. Clin Lung Cancer. 2015;16(5):385\u201390.","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"1989_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/annonc\/mdv489","volume":"27","author":"M Ilie","year":"2016","unstructured":"Ilie M, Long-Mira E, Bence C, Butori C, Lassalle S, Bouhlel L, et al. Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies. Ann Oncol. 2016;27(1):147\u201353.","journal-title":"Ann Oncol"},{"issue":"4","key":"1989_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cllc.2019.02.012","volume":"20","author":"H Elfving","year":"2019","unstructured":"Elfving H, Mattsson JSM, Lindskog C, Backman M, Menzel U, Micke P. Programmed Cell Death Ligand 1 Immunohistochemistry: a concordance study between surgical specimen, biopsy, and tissue microarray. Clin Lung Cancer. 2019;20(4):258\u201362.","journal-title":"Clin Lung Cancer"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-020-01989-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-020-01989-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-020-01989-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T20:21:09Z","timestamp":1615494069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-020-01989-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1989"],"URL":"https:\/\/doi.org\/10.1007\/s00595-020-01989-6","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"12 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Katsutaka Mineura and his co-authors have no conflicts of interest. Authors have nothing to disclose with regard to commercial support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}